VOLITIONRX LTD Reduces Authorized Common Shares to 150M

What Happened
VolitionRx Ltd. announced that it filed a Certificate of Fourth Amendment to its Second Amended and Restated Certificate of Incorporation in Delaware, effective upon filing on July 17, 2026. The amendment reduces the number of authorized shares of the company’s common stock (par value $0.001) from 325,000,000 to 150,000,000. The Board approved the amendment on May 11, 2026, and the company’s stockholders approved it at the Annual Meeting.

Key Details

• Authorized common shares reduced from 325,000,000 to 150,000,000.
• Amendment filed with the Delaware Secretary of State and became effective July 17, 2026.
• Board approval: May 11, 2026; stockholder approval: at the company’s Annual Meeting.
• Certificate of Fourth Amendment is filed as Exhibit 3.1 to the Form 8‑K.

Why It Matters
Reducing the number of authorized shares changes the maximum number of common shares the company can issue without a further charter amendment. For investors, this affects the company’s capacity to issue new shares for financing, acquisitions, equity compensation, or other corporate actions unless the charter is amended again. The filing documents the change and confirms it is effective as of July 17, 2026.